Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Tracks long-term treatment of heart disease patients in Niigata

Studies how heart disease patients in Niigata are treated over time, using insurance records.

Plain-language title generated from the registry record
Registry title: A Prognostic Study for Patients With Cardiovascular Disease in Niigata

Key facts

Where
Niigata, JapanSee the site

Where in Japan

  • Niigata UniversityNiigata, JapanNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Niigata University Medical & Dental Hospital
Trial code
NCT06992284
Record updated
28 May 2025
Original description
The goal of this observational study is to investigate the prognosis of cardiovascular disease in Niigata Prefecture.Read full original descriptionShow less

A Prognostic Study Using Health Insurance Claim for Patients With Cardiovascular Disease in Niigata

The goal of this observational study is to investigate the prognosis of cardiovascular disease in Niigata Prefecture.

Specifically, it aims to clarify the current status of medical treatment for cardiovascular disease patients in regional cities in Japan, where the population is aging.

With patient consent, the study will track long-term medical treatment progress using health insurance claim data recorded in Japan's unique social security system.

Inclusion: Individuals aged 18 or older at the time of enrollment (regardless of gender); Individuals who have been hospitalized in the cardiology department of a participating medical institution; Individuals covered by Japan's National Health Insurance (NHI) or the Late-stage Elderly Medical Care System, which provide health coverage for self-employed individuals, retirees, and the elderly.

Exclusion: Individuals who are unable to obtain consent from themselves or their legally authorized representatives.

ClinicalTrials.gov NCT06992284